Robert H. M. Christenson

Robert H. M. Christenson's AcademicInfluence.com Rankings

Philosophy

#6426

World Rank

#9461

Historical Rank

Logic

#3594

World Rank

#4782

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Robert H. M. Christenson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert H. M. Christenson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease (2009) (789)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. (2007) (720)
Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. (2010) (696)
Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia (1996) (671)
Biochemical markers of bone metabolism: an overview. (1997) (530)
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. (2010) (485)
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. (2005) (467)
The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study (2010) (447)
Evaluation of imprecision for cardiac troponin assays at low-range concentrations. (2004) (394)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. (2007) (376)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. (2007) (376)
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. (2012) (367)
Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. (2003) (362)
Relationship of depression to death or hospitalization in patients with heart failure. (2007) (341)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. (2007) (333)
Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. (2003) (310)
Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. (2014) (296)
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. (1998) (293)
Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. (2016) (288)
Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. (2001) (284)
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. (2001) (284)
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. (1996) (280)
N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study (2009) (270)
National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. (2007) (255)
Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study (2018) (246)
Influence of population selection on the 99th percentile reference value for cardiac troponin assays. (2012) (239)
Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status: The PARAGON-B Troponin T Substudy (2001) (233)
Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. (2002) (222)
Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. (2010) (218)
Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. (2009) (215)
Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. (1999) (207)
A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. (2002) (204)
Roadmap for harmonization of clinical laboratory measurement procedures. (2011) (199)
Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies (2003) (194)
National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. (2009) (188)
Quality specifications for B-type natriuretic peptide assays. (2005) (187)
Prognostic significance of elevated troponin I after percutaneous coronary intervention. (2002) (183)
Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. (2006) (179)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. (2007) (168)
Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). (2013) (166)
B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. (2006) (157)
Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin: Secondary Results From the Biomarkers in Acute Heart Failure (BACH) Study (2011) (156)
Biochemical markers of the acute coronary syndromes. (1998) (153)
Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing. (2007) (153)
Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure. (2010) (147)
The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. (2006) (146)
Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage (1999) (142)
Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications. (2006) (141)
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial (2012) (140)
Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. (2005) (140)
Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. (2012) (135)
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes (1998) (134)
Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. (2008) (133)
High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis) (2017) (125)
Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. (2011) (124)
Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. (2011) (123)
N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. (2005) (117)
Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials. (2001) (116)
Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. (2012) (114)
Performance of chronic kidney disease epidemiology collaboration creatinine‐cystatin C equation for estimating kidney function in cirrhosis (2014) (114)
Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. (2010) (113)
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. (1999) (112)
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. (2008) (108)
N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. (2018) (107)
Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). (2013) (107)
Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia (2010) (106)
Effectiveness of practices to reduce blood culture contamination: a Laboratory Medicine Best Practices systematic review and meta-analysis. (2012) (106)
Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. (2007) (102)
Cardiac troponin I measurement with the ACCESS immunoassay system: analytical and clinical performance characteristics. (1998) (102)
Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. (2006) (98)
N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. (2006) (96)
Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel (2021) (95)
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. (2015) (95)
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients. (2003) (94)
A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trial. (2009) (92)
Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated CopeptinClinical Perspective (2011) (92)
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study). (2004) (90)
Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study. (2016) (90)
High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. (2013) (90)
Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction. (2011) (86)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. (2007) (85)
Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy (2013) (83)
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. (2010) (82)
Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel. (2019) (82)
Intra- and interindividual variations in urinary concentrations of endogenous gamma-hydroxybutyrate. (2002) (82)
Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. (2003) (79)
Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. (2004) (76)
Analytical performance of the i-STAT cardiac troponin I assay. (2004) (76)
Amino-terminal pro-B-type natriuretic peptide: analytic considerations. (2008) (76)
Short-term mortality risk in emergency department acute heart failure. (2011) (76)
Standardisation of cardiac troponin I measurement: past and present (2010) (74)
Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. (2006) (72)
Changing the model of care for patients with acute coronary syndromes. (2003) (70)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. (2008) (70)
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. (2000) (69)
Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction (2018) (69)
Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing? (2002) (68)
The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test. (2016) (67)
N-Terminal ProB-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation The Cardiovascular Health Study (2009) (66)
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction (2005) (66)
Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative. (2004) (64)
Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. (2002) (64)
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I. (2019) (63)
Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study). (2015) (63)
Prodromal unstable angina in acute myocardial infarction: prognostic value of short- and long-term outcome and predictor of infarct size. (2000) (63)
Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response. (2003) (63)
All About Albumin: Biochemistry, Genetics, and Medical Applications. Theodore Peters, Jr. San Diego, CA: Academic Press, 1996, 432 pp, $85.00. ISBN 0-12-552110-3 (1997) (61)
Doping in the recombinant era: strategies and counterstrategies. (2005) (59)
Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department (2017) (58)
Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality. (2011) (58)
Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms. (2009) (58)
Effectiveness of barcoding for reducing patient specimen and laboratory testing identification errors: a Laboratory Medicine Best Practices systematic review and meta-analysis. (2012) (58)
Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). (2013) (58)
The National Academy of Clinical Biochemistry (2007) (58)
Sex-Specific 99th Percentile Upper Reference Limits for High Sensitivity Cardiac Troponin Assays Derived Using a Universal Sample Bank. (2020) (58)
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 (2012) (57)
Standardization of troponin I measurements: an update (2008) (57)
Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population (2016) (57)
Cardiac markers: point of care testing. (1999) (56)
Laboratory medicine best practices: systematic evidence review and evaluation methods for quality improvement. (2011) (56)
International survey on the use of cardiac markers. (2001) (56)
Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care. (2013) (54)
Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations. (2004) (54)
Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study (2015) (54)
Analysis of the Albumin cobalt Binding (ACBTM) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction (2007) (53)
Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase. (1998) (52)
Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. (2006) (52)
Cardiac biomarkers in heart failure. (2014) (51)
Leveraging the real value of laboratory medicine with the value proposition. (2016) (51)
Evidence-based laboratory medicine - a guide for critical evaluation of in vitro laboratory testing (2007) (50)
Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid. (2019) (50)
Standardization of creatine kinase-MB (CK-MB) mass assays: the use of recombinant CK-MB as a reference material. (1999) (49)
How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE). (2016) (48)
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7. (1997) (48)
Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study (2012) (47)
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. (1999) (47)
Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromes. (2005) (46)
Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function. (1993) (45)
Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study. (2002) (45)
Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality. (2010) (44)
Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes. (2004) (44)
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. (2013) (44)
Evidence-Based Laboratory Medicine: Principles, Practice, and Outcomes (2007) (44)
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays. (1999) (44)
Implications of troponin testing in clinical medicine (2001) (43)
Galectin 3 complements BNP in risk stratification in acute heart failure (2012) (43)
Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study (2019) (43)
Creatine kinase and its CK-MB isoenzyme: the conventional marker for the diagnosis of acute myocardial infarction. (1999) (42)
Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. (1987) (42)
B-Type Natriuretic Peptide: Physiologic Role and Assay Characteristics (2003) (42)
Effectiveness of automated notification and customer service call centers for timely and accurate reporting of critical values: a laboratory medicine best practices systematic review and meta-analysis. (2012) (42)
Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review. (2016) (41)
Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk. (2013) (41)
Results of dipstick tests, visual inspection, microscopic examination of urine sediment, and microbiological cultures of urine compared for simplifying urinalysis. (1985) (41)
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). (2007) (41)
Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin. (1987) (41)
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes. (2018) (40)
Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. (2007) (40)
The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. (2006) (40)
Characteristics of creatine kinase-MB and MB isoforms in serum after reperfusion in acute myocardial infarction. (1989) (39)
Total Analytic Error for Low Cardiac Troponin Concentrations (≤10 ng/L) by Use of a High-Sensitivity Cardiac Troponin Assay. (2017) (38)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure (2007) (37)
Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults. (2015) (37)
Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. (1983) (36)
Characteristics of myoglobin, carbonic anhydrase III and the myoglobin/carbonic anhydrase III ratio in trauma, exercise, and myocardial infarction patients. (2000) (36)
Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation. (2017) (35)
Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study. (2020) (35)
Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis. (2015) (34)
Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort. (2017) (34)
Gene doping: of mice and men. (2009) (34)
A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes. (2003) (33)
An Automated Assay for Growth Differentiation Factor 15. (2017) (33)
Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction. (1993) (33)
Influence of imprecision on ROC curve analysis for cardiac markers. (2006) (33)
Evidence based approach to practice guides and decision thresholds for cardiac markers. (1999) (33)
Arteriographic manifestations of pheochromocytoma. (1976) (32)
A Pilot Study to Evaluate Renal Hemodynamics in Cirrhosis by Simultaneous Glomerular Filtration Rate, Renal Plasma Flow, Renal Resistive Indices and Biomarkers Measurements (2014) (31)
Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. (1988) (31)
The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults (2020) (31)
The Role of Cardiac Biomarkers in the Diagnosis and Management of Patients Presenting with Suspected Acute Coronary Syndrome (2013) (30)
Sensitive and high sensitivity next generation cardiac troponin assays: more than just a name (2011) (30)
Biochemical markers in suspected acute myocardial infarction: the need for early assessment. (1995) (30)
Serum myoglobin for the early non-invasive detection of coronary reperfusion in patients with acute myocardial infarction. (1996) (29)
Prognostic significance of active and modified forms of endothelin 1 in patients with heart failure with reduced ejection fraction. (2014) (29)
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. (2009) (29)
Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis (2017) (28)
Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study. (2019) (28)
Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure. (2008) (28)
Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial. (2014) (27)
Pressure dressings and postarteriographic care of the femoral puncture site. (1976) (27)
Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trial. (2015) (27)
Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay. (2018) (26)
Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project (2015) (26)
Multicenter evaluation of analytical characteristics of the Elecsys® Periostin immunoassay. (2017) (26)
Comparison of 13 Commercially Available Cardiac Troponin Assays in a Multicenter North American Study. (2017) (26)
“Malignant” Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi‐Ethnic Study of Atherosclerosis) (2018) (26)
Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death? (2011) (25)
Lecithin cholesterol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain (1992) (25)
Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trial. (2015) (25)
Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review. (2015) (25)
Point: Put simply, standardization of cardiac troponin I is complicated. (2012) (25)
Impact of moderate physical activity on the longitudinal trajectory of a cardiac specific biomarker of injury: Results from a randomized pilot study of exercise intervention. (2016) (24)
Evaluating new diagnostic technologies: perspectives in the UK and US. (2008) (24)
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study (2019) (24)
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. (1998) (23)
Oxygen transport and cardiovascular effects of resuscitation from severe hemorrhagic shock using hemoglobin solutions. (1995) (23)
Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites (2016) (23)
Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals (2016) (23)
Two radioassays for serum vitamin B12 and folate determination compared in a reference interval study. (1985) (23)
Methodological and analytic considerations for blood biomarkers. (2012) (23)
Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction (2017) (23)
Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. (2016) (22)
B-type natriuretic peptide (BNP)/NT-proBNP and renal function: is the controversy over? (2009) (22)
Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction. (2019) (22)
Usefulness of prodromal unstable angina pectoris in predicting better survival and smaller infarct size in acute myocardial infarction (The InTIME-II Prodromal Symptoms Substudy). (2003) (22)
Elucidation of metanephrine to normetanephrine and epinephrine to norepinephrine ratios by fluorescence derivative spectroscopy (1982) (22)
Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis (2018) (22)
The case for cardiac troponin T: marker for effective risk stratification of patients with acute cardiac ischemia. (1996) (21)
Cardiac markers in the assessment of acute coronary syndromes. (1997) (21)
What is the value of B-type natriuretic peptide testing for diagnosis, prognosis or monitoring of critically ill adult patients in intensive care? (2008) (21)
Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung Cancer. (2019) (20)
Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction (2020) (20)
The Era for High-Sensitivity Cardiac Troponin Has Begun in the US (Finally). (2017) (20)
Multicenter study of Abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors. (1997) (20)
Ultrarapid Rule‐out for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay: Results From the REACTION‐US Study (2018) (20)
Plasma EGFR mutation testing in non-small cell lung cancer: A value proposition. (2019) (20)
Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. (2014) (19)
Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes. (2005) (19)
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. (2014) (19)
Determinants of elevated blood lead levels among working men in Greater Beirut. (2001) (19)
Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer. (2007) (19)
Prognostic Value of Troponins in Patients with Non‐ST‐segment Elevation Acute Coronary Syndromes and Chronic Kidney Disease (2008) (19)
Cardiac biomarkers - A short biography. (2015) (19)
Liver function and morphology after resuscitation from severe hemorrhagic shock with hemoglobin solutions or autologous blood. (1996) (19)
Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. (1996) (18)
Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS). (2016) (18)
Relative increase in creatine kinase MB isoenzyme during reperfusion after myocardial infarction is method dependent. (1990) (18)
Clinical performance characteristics of a new photometric lithium assay: a multicenter study. (2003) (18)
Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial). (2003) (17)
Eight compact analysis systems evaluated for measuring total cholesterol. (1994) (17)
Effects of dietary carbohydrate on 1,5‐anhydroglucitol in a population without diabetes: results from the OmniCarb trial (2017) (17)
Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults. (2018) (17)
Creation of a Universal Sample Bank for Determining the 99th Percentile for Cardiac Troponin Assays. (2017) (17)
Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes. (2009) (17)
Effects of Diet and Sodium Reduction on Cardiac Injury, Strain, and Inflammation: The DASH-Sodium Trial. (2021) (17)
Standardization of immunoassays for measurement of myoglobin in serum. Phase I: evaluation of candidate secondary reference materials. (2004) (17)
Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function (2009) (16)
Healthy diet reduces markers of cardiac injury and inflammation regardless of macronutrients: Results from the OmniHeart trial. (2020) (16)
Development of a candidate secondary reference procedure (immunoassay based measurement procedure of higher metrological order) for cardiac troponin I: I. Antibody characterization and preliminary validation (2010) (16)
Issues in cerebrospinal fluid management. Acid-fast bacillus smear and culture. (1991) (16)
Anti-inflammatory effects of pentoxifylline in claudication. (1991) (16)
Cardiac Microinjury Measured by Troponin T Predicts Collagen Metabolism in Adults Aged ≥65 Years With Heart Failure (2012) (15)
Procalcitonin as a biomarker for early sepsis in the emergency department (2014) (15)
Early detection of myocardial ischemia by a novel blood-based biomarker: The kinetics of ischemia modified albumin (2003) (15)
Bioavailability of digoxin capsules and tablets: effect of coadministered fluid volume. (1984) (15)
Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study Group. (1995) (14)
Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction. (1993) (14)
Cardiac and muscle disease (1996) (14)
Stability of B-type natriuretic peptide (BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systems. (2007) (14)
Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV (2019) (14)
Ask the right question: a critical step for practicing evidence-based laboratory medicine* (2013) (13)
High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus (2018) (13)
Evolving role of galectin-3 as a cardiac biomarker: heart failure with preserved ejection fraction and renal function, important pieces of the puzzle. (2015) (13)
Post-discharge changes in NT-proBNP and quality of life after acute dyspnea hospitalization as predictors of one-year outcomes. (2010) (13)
Heart failure biomarkers at point-of-care: current utilization and future potential (2014) (13)
Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department. (2017) (13)
Preamble: National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for utilization of biomarkers in acute coronary syndromes and heart failure. (2008) (13)
The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study (2017) (13)
National academy of clinical biochemistry laboratory medicine practice guidelines: Point of care testing, oversight, and administration of cardiac biomarkers for acute coronary syndromes (2007) (12)
Characteristics of a 20-minute whole blood rapid assay for cardiac troponin T. (1997) (12)
Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition. (2020) (12)
A routine method for the determination of digoxin in urine by radioimmunoassay. (1982) (12)
Abbott AxSYM Vancomycin II assay: multicenter evaluation and interference studies. (1998) (12)
High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study (2017) (12)
Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke (2009) (12)
Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial (2015) (12)
A value proposition for natriuretic peptide measurement in the assessment of patients with suspected acute heart failure. (2019) (12)
Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial (2016) (11)
Characteristics of cardiac troponin measurements (2013) (11)
Associations Between Dietary Patterns and Subclinical Cardiac Injury (2020) (11)
Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure (2020) (11)
Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry system. (2009) (11)
Pivotal Findings for a High-Sensitivity Cardiac Troponin Assay: Results of the HIGH-US Study. (2020) (11)
Diagnostic Performance of High Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite United States Cohort. (2021) (11)
737–5 Risk Stratification in Acute Ischemic Syndromes Using Serum Tropenin T (1995) (11)
Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study (2019) (10)
Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea. (2020) (10)
A Novel Approach to Hematology Testing at the Point of Care (2020) (10)
Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers (2021) (9)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure. (2007) (9)
Predictive Performance of Traumatic Brain Injury Biomarkers in High-Risk Elderly Patients. (2019) (9)
Effect of Eptifibatide for Acute Coronary Syndromes: Rapid Versus Late Administration—Therapeutic Yield on Platelets (The EARLY Platelet Substudy) (2002) (9)
Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. (2015) (9)
Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study (2016) (9)
Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV (2018) (9)
Clinical Application of Serologic Testing for Coronavirus Disease 2019 in Contemporary Cardiovascular Practice (2021) (9)
Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304 (2011) (9)
Myocardial Infarction Can Be Safely Excluded by High‐sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation (2020) (9)
Associations of microvascular dysfunction with cardiovascular outcomes: The cardiac, endothelial function and arterial stiffness in ESRD (CERES) cohort (2019) (9)
Specificity of an immunochemical reagent for quantifying the isoforms of creatine kinase‐MB (1993) (9)
Cerebrospinal fluid (CSF) TRAP. A method to improve CSF laboratory efficiency. (1988) (9)
Response by Allen et al to Letter Regarding Article, "Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort". (2021) (8)
Serum release of the creatine kinase tissue-specific isoforms MM3 and MB2 is simultaneous during myocardial reperfusion. (1991) (8)
Associations Between Cardiac Biomarkers and Cardiac Structure and Function in CKD (2020) (8)
Communications: Gentamicin Concentrations in Toadfish and Goldfish Serum (1997) (8)
Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. (2020) (8)
Biomarkers of Myocardial Necrosis (2006) (8)
Biomarkers of ischemia in patients with known coronary artery disease: do interleukin-6 and tissue factor measurements during dobutamine stress echocardiography give additional insight? (2005) (8)
Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD. (2021) (8)
Issues in cerebrospinal fluid management. CSF Venereal Disease Research Laboratory testing. (1991) (8)
SOLUBLE ST2 AND GALECTIN-3 ARE ASSOCIATED WITH SUBCLINICAL DIASTOLIC DYSFUNCTION IN OLDER ADULTS (2014) (7)
In vitro interference of the red cell substitute pyridoxalated hemoglobin-polyoxyethylene with blood compatibility, coagulation, and clinical chemistry testing. (1997) (7)
Clinical Validation of a Novel Assay for Galectin-3 for Risk Assessment in Acutely Destabilized Heart Failure (2009) (7)
Myocardial Ischemia on Exercise Stress Echocardiography Testing Is Not Associated with Changes in Troponin T Concentrations. (2017) (7)
Are Heart Failure Management Recommendations and Guidelines Followed in Laboratory Medicine in Europe and North America? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) Study. (2017) (7)
Optimal Detection of Acute Myocardial Injury and Infarction with Cardiac Troponin: Beyond the 99th Percentile, into the High-Sensitivity Era (2020) (7)
Increased lactate dehydrogenase isoenzyme 1 in serum and tumor tissue of a patient with small-cell carcinoma. (1986) (7)
Testing at the Point-of-Care: Errors of Omission in the Patient Care Pathway (2011) (6)
Thyroid function testing evaluated on three immunoassay systems (1995) (6)
Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System. (2011) (6)
Laboratory medicine best practices : developing systematic evidence review and evaluation : methods for quality improvement phase 3 final technical report (2010) (6)
N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation The Cardiovascular Study (2009) (6)
Performance of four automated SARS-CoV-2 serology assay platforms in a large cohort including susceptible COVID-19 negative and COVID-19 positive patients (2021) (6)
Differentiating type 1 and 2 acute myocardial infarctions using the N‐terminal pro B‐type natriuretic peptide/cardiac troponin T ratio (2018) (6)
Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes. (2007) (6)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Heart Failure: Preamble (2007) (6)
Nourin-Dependent miR-137 and miR-106b: Novel Early Inflammatory Diagnostic Biomarkers for Unstable Angina Patients (2021) (6)
Copeptin to rule out myocardial infarction in Blacks versus Caucasians (2019) (6)
Analytical and Clinical Characterization of a Novel High-Sensitivity Cardiac Troponin Assay in a United States Population. (2020) (5)
Necessity of hospitalization and stress testing in low risk chest pain patients (2017) (5)
884-3 Clinical implications of discordant creatine kinase-MB and troponin results in patients with acute coronary syndromes (2004) (5)
Performance characteristics of a revised cardiac Troponin I assay for the Opus plus immunoassay system. (2001) (5)
Oligoclonal banding in cerebrospinal fluid assessed by electrophoresis on agarose after centrifugal sample concentration through a microconcentrator membrane. (1985) (5)
Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease. (2020) (5)
Multisite Study of a Second Generation Whole Blood Rapid Assay for Cardiac Troponin T (1999) (5)
Novel mediators of statin effects on plaque in HIV: a proteomics approach (2018) (5)
Searching for evidence: a guide to finding the evidence in laboratory medicine (2014) (5)
Improving the reliability of total and high-density lipoprotein cholesterol measurements. Four testing strategies compared in a high-risk population. (1991) (5)
Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome (2021) (5)
Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure (2020) (5)
Relationship between serum lactate and ionized calcium in open-heart surgery. (1986) (5)
Two-center clinical evaluation of a new automated fluorometric immunoassay for the quantitative analysis of total betaeta-human chorionic gonadotropin. (2003) (4)
The utility of risk scores when evaluating for acute myocardial infarction using high-sensitivity cardiac troponin I. (2020) (4)
IMPROVED SURVIVAL IN PATIENTS WITH DIASTOLIC HEART FAILURE DISCHARGED ON BETA-BLOCKER AND ACE INHIBITORS (2013) (4)
Multiple Cardiac Biomarker Testing Among Patients with Acute Dyspnea from the ICON-RELOADED Study. (2021) (4)
The standards for reporting diagnostic accuracy studies 2015 update: is there a missing link to the triumvirate? (2016) (4)
A Multicenter Evaluation of a Nongel Mechanical Separator Plasma Blood Collection Tube for Testing of Selected Therapeutic Drugs. (2020) (4)
Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide (2018) (4)
Point-of-Care Testing for Cardiac Markers (1998) (4)
High-Sensitivity Cardiac Troponin Assays Potentially Differentiate Acute From Chronic Myocardial Injury. (2019) (4)
The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea (2012) (4)
Simplified fluorometry of total metanephrines in urine. (1982) (4)
Nourin-Dependent miR-137 and miR-106b: Novel Biomarkers for Early Diagnosis of Myocardial Ischemia in Coronary Artery Disease Patients (2021) (4)
Institute for Quality in Laboratory Medicine series--controversies in laboratory medicine: insights into B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide measurements. (2006) (4)
Recommendation to harmonize the units for reporting cardiac troponin results. (2014) (4)
1154-90 Suboptimal treatment of patients with non-ST elevation acute coronary syndromes presenting with positive baseline troponin values (2004) (4)
Abstract 13103: Nourin-dependent Mirna-106b : A Novel Early Inflammatory Diagnostic Biomarker for Cardiac Injury (2020) (3)
The Relationship of Falls With Achieved 25-Hydroxyvitamin D Levels From Vitamin D Supplementation: The STURDY Trial (2022) (3)
Robust Metabolomic Signature is Associated with Altered Renal Hemodynamics in Patients with Cirrhosis (2017) (3)
Nourin-Associated miRNAs: Novel Inflammatory Monitoring Markers for Cyclocreatine Phosphate Therapy in Heart Failure (2021) (3)
Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarction. (2002) (3)
Predictive Performance of Traumatic Brain Injury Biomarkers in High-Risk Elderly Patients. (2020) (3)
Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction. (2020) (3)
Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol (2022) (3)
The focused review process: a utilization management firm's experience with length of stay guidelines. (1995) (3)
Automated determination of apolipoprotein AI and apolipoprotein E in cerebrospinal fluid. (1986) (3)
Suboptimal adherence to the ACC/AHA non-ST elevation acute coronary syndrome practice guidelines for patients with positive troponin levels (2003) (3)
Relation of Biomarkers of Cardiac Injury, Stress, and Fibrosis with Cardiac Mechanics in Individuals ≥ 65 Years of Age. (2020) (3)
Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapies. (2001) (3)
Establishment of a CSF bank (1988) (3)
Predictors of 30-day cardiovascular events in patients with prior percutaneous coronary intervention or coronary artery bypass grafting. (2011) (3)
1-h Evaluation for Acute Myocardial Infarction Using the Generation 5 Cardiac Troponin T Assay. (2018) (3)
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction∗∗A complete list of the TAMI Study Group appears in J Am Coll Cardiol 1992;19:482–489. (2000) (3)
Serum Markers for Diagnosis and Risk Stratification in Acute Coronary Syndromes (1999) (3)
Cardiorespiratory Fitness and Highly Sensitive Cardiac Troponin Levels in a Preventive Medicine Cohort (2013) (3)
Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection? (2020) (3)
Diagnostic utility of a single-epitope sandwich B-type natriuretic peptide assay in stable coronary artery disease: data from the Akershus Cardiac Examination (ACE) 1 Study. (2012) (2)
Prevalence of Proteinuria and Elevated Serum Cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) Study (2012) (2)
Defining the Path Forward: Guidance for Laboratory Medicine Guidelines (2015) (2)
Cardiac troponin T in the risk assessment of acute coronary syndromes. (1997) (2)
Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals (2022) (2)
Production and characterization of monoclonal antibodies to human carbonic anhydrase III. (1998) (2)
Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes. (2017) (2)
Abstract 13051: Nourin-dependent Mirna-137 : A Novel Early Diagnostic Biomarker for Unstable Angina Patients (2020) (2)
SOLUBLE ST2 PREDICTS INCIDENT HEART FAILURE AND CARDIOVASCULAR DEATH IN OLDER ADULTS (2014) (2)
Implementation of Medical Tests in a Value-Based Healthcare Environment A framework for delivering value. (2021) (2)
Glycated Albumin for the Diagnosis of Diabetes in US Adults. (2022) (2)
The ABCs of clinical biochemistry. (2012) (2)
CSF TRAP: a procedure to improve laboratory testing with myelography. (1989) (2)
Outpatient versus Observation/Inpatient Management of Emergency Department Patients Rapidly Ruled-out for Acute Myocardial Infarction: Findings from the HIGH-US Study. (2020) (2)
Performance characteristics of a new myoglobin microparticle enzyme immunoassay: a multicenter evaluation. (2000) (2)
Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study (2021) (2)
Roche and Abbott carcinoembryonic antigen assays compared. (1982) (2)
Comparison of 13 Commercially Available Cardiac Troponin Assays in a Multicenter North American Study. (2017) (2)
Abstract 12104: Absolute and Relative Changes (Delta) in Troponin I for Early Diagnosis of Myocardial Infarction: Results of a Prospective Multicenter Trial (2014) (2)
737–6 Combining Myoglobin and Clinical Variables for Assessing Coronary Reperfusion After Thrombolytic Therapy (1995) (2)
High-sensitivity cardiac troponin T and secondary events in outpatients with coronary heart disease from the Heart and Soul Study (2013) (2)
Abstract 16698: Rapid Evaluation of Acute Myocardial Infarction Using a Change in High-Sensitivity Cardiac Troponin T Over 1 Hour (2017) (2)
High-sensitivity troponin i: One-hour evaluation for acute myocardial infarction in the United States (2019) (2)
Establishment of a Cerebrospinal Fluid Bank (1990) (2)
Glycated Albumin and Risk of Mortality in the US Adult Population. (2022) (2)
Preamble: 'evidence in action: the Laboratory Medicine Best Practice initiative'. (2012) (2)
Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting. (2022) (2)
Translation: Roadmap for Harmonization of Clinical Laboratory Measurement Procedures* (2012) (2)
Insights Into Development of the National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Point-of-Care Testing for Biomarkers of Cardiac Injury (2006) (2)
PEER REVIEWED PUBLICATIONS 1. Ali YS, Maron DJ. Screening for coronary disease in diabetes: when and how. Clin Diabetes 2006; 24:169- 173. (2007) (2)
Serum Creatinine in Female Patients with Cirrhosis Unfairly Bias Liver Transplant Wait List Ranking: Implications for Elimination of Gender Disparities in Access to Orthotopic Liver Transplantation (2017) (1)
Troponin I elevation following percutaneous coronary intervention does not predict future adverse outcomes (2003) (1)
Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction. (2021) (1)
Abstract 19277: Statin Therapy Lowers Myocardial Fibrosis Marker sST2 in Patients Living With HIV (2016) (1)
Working Group on Emergency Department Management of Acute Heart Failure Research Challenges and Opportunities (1)
Multicenter evaluation of the Abbott AxSYM procainamide and N-acetylprocainamide assays: comparison with Abbott TDx/TDxFLx, Syva EMIT 2000, DuPont ACA, and HPLC methods. (1998) (1)
Rapid evaluation of acute myocardial infarction in a united states population using high sensitivity cardiac troponin T and a European society of cardiology 0/1-hour algorithm guideline. (2018) (1)
Assessing Phlebotomy Device Preference and Specimen Quality in an Oncology Outpatient Clinic. (2021) (1)
Abstract 047: Effects Of The Dash Diet On Change In High-Sensitivity Cardiac Troponin I Over Time: Results From The Dash-Sodium Trial (2022) (1)
CYFRA 21-1 (CYFRA) as a prognostic and predictive marker in advanced non-small cell lung cancer (NSCLC): CALGB 150304. (2009) (1)
A rapid BNP assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter study (2002) (1)
Measurements Matter. (2016) (1)
Out of the Darkness, Into the Light: Value of SARS-CoV-2 Antibody Testing in Populations to Benefit Public Health and in Individuals for Peace of Mind (2020) (1)
Immunochemical assays for IgG, IgA, IgM and transferrin compared. (1989) (1)
Evaluation of the Elecsys Syphilis Immunoassay for Detection of Syphilis in Populations at Risk of Disease in the US and Argentina. (2018) (1)
The troponin decision-point dilemma: The 99th percentile solution "do the best you can [with cardiac troponin] until you know better. Then when you know better, do better." Maya Angelou, poet, dancer, producer, playwright, director, author. (2017) (1)
Prognostic Utility of a Modified HEART Score When Different Troponin Cut Points Are Used (2021) (1)
Natriuretic Peptides and Echocardiography in Unselected Acute Dyspnea Patients: Implication of Elevated Levels with Normal Systolic Function (2008) (1)
Poster Sessions (2014) (1)
PROGNOSTIC UTILITY OF A MODIFIED HEART SCORE WHEN DIFFERENT TROPONIN CUT-POINTS ARE USED (2019) (1)
Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child–Turcotte–Pugh Class C Cirrhosis and Renal Dysfunction (2015) (1)
272EMF Using Monocyte Chemoattractant Protein-1 to Predict Adverse Cardiovascular Events among Emergency Department Chest Pain Patients (2020) (1)
Abstract 16937: Initiation of Moderate Physical Activity Reduces Progression of Subclinical Cardiac Injury in Previously Sedentary Older Adults: Results From a Randomized Pilot Study of Exercise Intervention (2013) (1)
Myocardial salvage after reperfusion (1992) (1)
COPEPTIN PROVIDES PROGNOSTIC VALUE IN PATIENTS WITH ACUTE CHEST PAIN (2014) (1)
Point-of-Care Testing for Biochemical Markers of Acute Coronary Syndromes (2002) (1)
Biochemical markers and the era of troponin. (2001) (1)
PERFORMANCE OF A NOVEL HIGH SENSITIVITY CARDIAC TROPONIN I ASSAY FOR A ONE HOUR ALGORITHM FOR EVALUATION OF NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION IN THE UNITED STATES (2019) (1)
Practice Guidelines : Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure (2007) (1)
Biomarker differentiation of type 1 from type 2 acute myocardial infarction in the emergency department: NTerminal pro B-type natriuretic peptide/high-sensitivity cardiac troponin T. (2018) (1)
COMBINED PREDICTIVE VALUE OF DEPRESSION AND B-TYPE NATRIURETIC PEPTIDE FOR MORTALITY IN HEART FAILURE PATIENTS: THE CARDIOVASCULAR HEALTH STUDY (2010) (1)
NOVEL BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR IDENTIFYING ASYMPTOMATIC PROGRESSION TO A LOW LVEF IN COMMUNITY DWELLING OLDER ADULTS (2014) (1)
RISK STRATIFICATION OF CHEST PAIN IN THE EMERGENCY DEPARTMENT: INCORPORATING A HIGH-SENSITIVITY TROPONIN ASSAY INTO EXISTING RISK TOOLS (2019) (1)
BNP and N-terminal pro BNP: clinical utilisation in diagnosis, prognosis, and risk stratification (2005) (1)
Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure National Academy of Clinical Biochemistry Laboratory Medicine Practice (2008) (1)
Do glycoprotein IIb/IIIa inhibitors interact with assays for myocardial necrosis? (2003) (1)
Highly Sensitive Cardiac Troponin T Assay, Cardiac Disease, and Mortality Risk—Reply (2011) (1)
Two of the authors of the article cited in the two preceding letters respond (1998) (1)
GALECTIN-3 PREDICTS CARDIOVASCULAR EVENTS IN OLDER ADULTS (2014) (1)
42 Is the European Society of Cardiology 0- and 1-Hour Algorithm Guidelines for Rapid Evaluation of Acute Myocardial Infarction Effective at 0 Hour and 30 Minutes (2017) (1)
Health economic evaluations of medical tests: Translating laboratory information into value – A case study example (2021) (1)
Abstract 16085: Baseline High Sensitivity Troponin T Value Below the Level of Detection to Rule-Out Acute Myocardial Infarction in the United States (2017) (1)
Scientific charge master rate optimisation, knowing things that can go wrong and how to avoid them (2006) (1)
Lyophilizing effects on cerebrospinal fluid stored at -70 degrees C. (1988) (1)
Diagnostic enzymology. (1989) (1)
Critical appraisal in the practice of laboratory medicine (2016) (1)
Abstract 51: Effects of Dietary Patterns on Subclinical Cardiac Damage: Results From the DASH Trial (2020) (1)
Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome (2022) (1)
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease. (2023) (1)
Distribution of High-Sensitivity Cardiac Troponin and N-Terminal Pro-Brain Natriuretic Peptide in Healthy Transgender People. (2022) (1)
The Emit® 2000 Cyclosporine Specific Assay, Extended Range: Development of an application protocol for the V‐Twin® Analyzer (2011) (1)
Galectin-3 and soluble ST2 and kidney function decline in older adults: the Cardiovascular Health Study (2019) (1)
5 Adverse Outcomes 30 Days After Emergency Department Evaluation for Myocardial Infarction Determined Solely by High Sensitivity Troponin I Values for a 1-Hour Rule-Out/Rule-In Acute Myocardial Infarction Algorithm (2019) (1)
Multisite evaluation of a monoclonal IMMULITE erythropoietin immunoassay. (2014) (1)
Abstract 023: Effects Of Sodium Reduction And The Dash Diet On Subclinical Cardiac Damage: Results From The Dash-Sodium Trial (2021) (1)
271EMF Advancing Emergency Department Chest Pain Risk Stratification With Monocyte Chemoattractant Protein-1 and High-Sensitivity Troponin (2020) (1)
Prediction of Incident Heart Failure in CKD: The CRIC Study (2022) (1)
Point-of-Care: Roadmap for Analytical Characterization and Validation of a High-Sensitivity Cardiac Troponin I Assay in Plasma and Whole Blood Matrices. (2022) (1)
Assessing Reperfusion and Prognostic Infarct Sizing with Biochemical Markers: Practice and Promise (2003) (1)
A215 HEMOSTATIC AND HEMATOLOGICAL PROFILES WITH FREE HEMOGLOBIN SOLUTIONS FOLLOWING RESUSCITATION FROM SEVERE HEMORRHAGIC SHOCK IN DOGS (1997) (1)
MULTICENTER EVALUATION OF THE ANALYTICAL CHARACTERISTICS OF THE ELECSYS® TOTAL-TAU CEREBROSPINAL FLUID (CSF) AND ELECSYS® PHOSPHO-TAU (181P) CSF IMMUNOASSAYS (2018) (1)
UNIVANTS of Healthcare Excellence: More Than an Award. (2022) (0)
Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control- National Health and Nutrition Examination Survey, 1999-2004 (2023) (0)
IMPACT OF MALIGNANT LEFT VENTRICULAR HYPERTROPHY ON INCIDENT ASYMPTOMATIC LEFT VENTRICULAR DYSFUNCTION: THE MESA STUDY (2017) (0)
Abstract 18580: High Sensitivity Cardiac Troponin Sex Specific 99th Percentiles Derived From Universal Sample Bank (2017) (0)
Derivation and Validation of a High Sensitivity Troponin-T HEART Pathway. (2022) (0)
Determination of the falloff constant (kf) from modeling biochemical marker release (2007) (0)
Cardiac Markers: A Chest Pain Center Focus (2009) (0)
A multicenter performance evaluation of the new Elecsys Vitamin D total III assay versus reference isotope dilution liquid chromatography tandem mass spectrometry and commercially available comparators (2022) (0)
Stress-Delta B-Type Natriuretic Peptide Does Not Exclude ACS in the ED. (2022) (0)
Abstract 17021: High Sensitive Cardiac Troponin T is Associated With Progression of Subclinical CVD: the Multi-Ethnic Study of Atherosclerosis (MESA) (2016) (0)
High Sensitivity Troponin I: One Hour Evaluation for Myocardial Infarction in the United States (2020) (0)
Cutoff for a rapid whole blood cardiac troponin T assay (1996) (0)
Heterogeneity of infarct sizing in non-ST segment elevation acute coronary syndromes: results from the EARLY pilot trial (2002) (0)
Characteristics of a Two-SiteImmunoradiometric Assayfor HumanSkeletalAlkaline Phosphatasein Serum (1994) (0)
109 Delayed Stress Delta N-Terminal Pro-B Type Natriuretic Peptide Is Significantly Higher With Myocardial Ischemia (2015) (0)
Hospitalization of Low Risk Chest Pain Patients With Normal Troponin and Copeptin (2016) (0)
Thirty-Day Follow-Up NT-proBNP Levels after Emergency Department Visit for Acute Dyspnea: Association with Symptoms and Prediction of Survival (2008) (0)
Letter to the Editor | Clinical Biochemistry - Volume 40, Issues 1–2 (2007) (0)
One and Done? Performance of a single, low high-sensitivity troponin in a multisite United States cohort (2020) (0)
Does Copeptin Provide Additional Risk Stratification in Chest Pain Patients With a Mild Troponin Elevation (2014) (0)
Non-ST-Segment Elevation Acute Coronary Syndrome Mortality: An Analysis of B-Type Natriuretic Peptide and Cardiac Troponin (2005) (0)
A-067 The NT-proBNP level in Subclinical stage of cardiac structural or functional abnormalities among health checkups (2018) (0)
P5005Diagnostic and prognostic utilities of insulin-like growth factor-binding protein-7 in patients presenting to the emergency department with dyspnea: results from the ICON-RELOADED study (2019) (0)
Patients with low high-sensitivity troponin i values have similar outcomes whether discharged or hospitalized (2020) (0)
Corrigendum to “Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction” [Clin. Chim. Acta 346 (2004) 211–219] (2005) (0)
proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain : Results from the CHOPIN trial Permalink (2015) (0)
Relationshipbetween Serum Lactateand IonizedCalciumin Open-Heart Surgery (1986) (0)
Associations of Glycated Albumin and HbA1c with Chronic Kidney Disease in US Adults. (2022) (0)
Corrigendum to 'Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay' [Clin. Biochem. 56 (2018) 4-10]. (2018) (0)
Abstract 14862: Prediction of Myocardial Infarct Size Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention (2011) (0)
Use of heparinized samples for salicylate determination with the DuPont aca validated. (1983) (0)
Books and Software: A Starting Point for CE. (2001) (0)
Proteins: analysis and interpretation in serum, urine, and cerebrospinal fluid (2020) (0)
Performance evaluation of the Beckman Coulter DxN VERIS Hepatitis C Assay on the DxN VERIS MDx system (2015) (0)
The use in the United States of a baseline high-sensitivity cardiac troponin t value below the level of detection to rule out acute myocardial infarction. (2018) (0)
Glycated albuminandHbA1cas markers of lower extremity disease inUS adults with and without diabetes. (2022) (0)
Serum VEGF and COX-2/5LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304. (2010) (0)
Abstract 3106: Longitudinal Changes in NT-proBNP Predict New Onset Heart Failure in Community-Dwelling Older Adults: The Cardiovascular Health Study (2008) (0)
Second‐generation fully automated Elecsys cerebrospinal fluid immunoassays demonstrate high precision, reproducibility, and sample stability suitable for clinical use to aid Alzheimer’s disease diagnosis (2022) (0)
The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States (2021) (0)
Ideal one-hour delta high-sensitivity troponin cutoffs for myocardial infarction in patients with renal dysfunction (2019) (0)
INTERLEUKIN FAMILY MEMBER ST2 AND MORTALITY IN ACUTE DYSPNEA (2010) (0)
101 Differentiating Type 1 from Type 2 Acute Myocardial Infarction in the Emergency Department Using the N-terminal Pro B-type Natriuretic Peptide/High-sensitivity Cardiac Troponin T Ratio (2022) (0)
THE PROGNOSTIC UTILITY OF A MODIFIED HEART SCORE IN PATIENTS WITH CHEST PAIN IN THE EMERGENCY DEPARTMENT APPLIED TO THE TRAPID-AMI STUDY (2015) (0)
Sex and Race Differences in the Performance of the European Society of Cardiology 0/1-Hour Algorithm with High-Sensitivity Troponin T (2023) (0)
Biochemical Markers for Diagnosis of Myocardial Infarction—Cardiac Troponin (2007) (0)
Review Implications of troponin testing in clinical medicine (2001) (0)
Standardization of troponin I measurements : an update 1 ) (2008) (0)
Abstract 18591: Identifying “At-Risk” Elderly Persons for New Onset Heart Failure: Implications for Assessment of High-Sensitive Troponin T. (2010) (0)
European society of cardiology 0-hour/1-hour high-sensitivity troponin algorithm performance in a United States cohort (2020) (0)
CHARACTERISTICS OF CHEST PAIN PATIENTS WITHOUT ACUTE CORONARY SYNDROMES STRATIFIED BY A “HYPER-SENSITIVE” TROPONIN I ASSAY (2010) (0)
41 A Baseline and 30-Minute Algorithm for Rapid Rule-Out of Acute Myocardial Infarction: Does it Get Any Better Than This? (2017) (0)
Abstract 16594: Elevated Levels of Galectin-3 are Associated with Higher Levels of C-Reactive Protein, Increased Disease Severity and Poorer Prognosis in Patients with Chronic Heart Failure (2012) (0)
LONG-TERM TRAJECTORY OF TWO UNIQUE CARDIAC BIOMARKERS AND SUBSEQUENT LEFT VENTRICULAR STRUCTURAL PATHOLOGY AND RISK OF INCIDENT HEART FAILURE IN COMMUNITY DWELLING OLDER ADULTS (2012) (0)
Abstract 4778: Postoperative ST2 Blood Concentrations Predict One Year Mortality in Coronary Artery Bypass Patients (2008) (0)
387 Dispositions for Patients Ruled Out for Acute Myocardial Infarction Using a 1-Hour High Sensitivity Troponin I Algorithm: Home or Hospital? (2020) (0)
Harmonized laboratory results are in tune with effective healthcare goals. (2014) (0)
Eight CompactAnalysis Systems Evaluatedfor MeasuringTotal Cholesterol (1994) (0)
IMPACT OF MALIGNANT LEFT VENTRICULAR FUNCTION ON INCIDENT HEART FAILURE IN OLDER ADULTS: THE MESA STUDY (2017) (0)
Contents Vol. 39, 2014 (2014) (0)
Improved Mortality Associated with ACE-I and Beta Blocker Therapy in Heart Failure with Preserved Ejection Fraction: An Analysis of the Biomarkers in Acute Heart Failure (BACH) Trial (2009) (0)
Evidence-based laboratory medicine (2020) (0)
Abstract 35: The Effect of Type and Amount of Dietary Carbohydrate on Biomarkers of Glucose Homeostasis and Inflammation in Healthy Adults: Results From The Omnicarb Trial (2016) (0)
SERUM ST2 IS A STRONGER PROGNOSTIC MARKER THAN HIGH SENSITIVITY TROPONIN-I IN ACUTE DYSPNEA PATIENTS (2012) (0)
Abstract 19811: Circulating Soluble ST2 Levels are Independent of Cardiac Production after Acute Myocardial Injury (2014) (0)
RISK ASSESSMENT OF EMERGENCY DEPARTMENT PATIENTS WITH HIGH SENSITIVITY CARDIAC TROPONIN I CONCENTRATIONS BELOW THE 99TH PERCENTILE SEX-SPECIFIC UPPER REFERENCE LIMITS (2021) (0)
Predictors of Stress-Delta High-Sensitivity Troponin T in Emergency Department Patients Undergoing Stress Testing (2022) (0)
The Role of Enzymatic Markers in the New Millennium: Point-of-Care Testing and Beyond (1998) (0)
Echocardiography Give Additional Insight? Interleukin-6 and Tissue Factor Measurements During Dobutamine Stress Biomarkers of Ischemia in Patients With Known Coronary Artery Disease: Do (2010) (0)
William Edward Highsmith. (2018) (0)
[The ways of harmonization of clinical laboratory measurement techniques]. (2013) (0)
Outcomes in ED patients with non‐specific ECG findings and low high‐sensitivity troponin (2022) (0)
Any Troponin Elevation Is Associated with Increased Mortality in Patients with Non-ST-Elevation Acute Coronary Syndromes Despite Variations in Hospital Laboratory Assays and Presence of Renal Insufficiency (2005) (0)
Special Collection on the Value of Laboratory Medicine. (2020) (0)
A Single High Sensitivity Cardiac Troponin I Measurement from Siemens Healthineers Can Be Used to Rule out Acute Myocardial Infarction at Low Risk in Patients Presenting to the Emergency Department (2018) (0)
INTERPRETING CARDIAC TROPONINS WHEN MEASURED IN ASYMPTOMATIC PATIENTS AND FOLLOWING ACUTE INJURY (2018) (0)
Performance characteristics of an ECL immunoassay for the quantitation of serum periostin (2016) (0)
Patterns of Daily Physical Movement, Chronic Inflammation, and Frailty Incidence (2022) (0)
The Diagnostic and Prognostic Utility of Circulating Serum Myeloperoxidase Levels in Patients Presenting with Dyspnea (2008) (0)
PREDICTION OF DEATH AND CONGESTIVE HEART FAILURE USING MULTIPLE CONCOMITANT ANGIOGRAPHIC BIOCHEMICAL AND ELECTROCARDIOGRAPHIC BIOMARKERS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2011) (0)
Aprotinin Inhibits Myocardial Reperfusion Injury During Off-Pump Coronary Artery Bypass Grafting: Results From A Randomized, Prospective, Double-Blinded Study: P29 (2006) (0)
Inverse Associations between Measures of Adiposity and Glycated Albumin in US Adults, NHANES 1999-2004. (2023) (0)
Abstract P416: Higher Quality Diet is Associated With Lower Serum Levels of NT-proBNP (2023) (0)
Age and the European Society of Cardiology 0/1-hour high sensitivity troponin T algorithm for the evaluation of patients with possible acute myocardial infarction: results from the STOP-CP study (2022) (0)
INTERPRETING NEW HIGH SENSITIVE TROPONIN I AND T ASSAYS IN THE SETTING OF CHRONIC KIDNEY DISEASE (2010) (0)
CHANGE IN ST2 LEVEL: REFINING RISK STRATIFICATION IN THE DYSPNEA PATIENT (2010) (0)
Increasing the Chance to Hit: Risk Factors for Heparin-Induced Thrombocytopenia in Cardiothoracic Surgery Patients (2020) (0)
Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis (2023) (0)
Do High-Sensitivity Cardiac Troponin I Clinical Performance Data in Package Inserts Reflect Realistic Clinical Expectations? (2018) (0)
Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction (2017) (0)
Abstract 12641: High-Sensitive troponin-T Strongly Predicts Cardiovascular Mortality in Community-Dwelling Older Adults: the Cardiovascular Health Study (2010) (0)
Special section: utilization of B-type natriuretic peptide and N-terminal B-type natriuretic peptide in laboratory medicine. Foreword. (2008) (0)
BIOMARKER MODEL FOR CORONARY ARTERY DISEASE (2016) (0)
TwoRadioassays forSerumVitamin B12andFolateDetermination Compared ina Reference Interval Study (1985) (0)
Abstract 16145: Significance of High-sensitivity Cardiac Troponin T Levels Between the Limit of Blank and the Limit of Detection in the General Population: A Meta-analysis (2015) (0)
T Cell Responses Correlate with Self-Reported Disease Severity and Neutralizing Antibody Responses Predict Protection against SARS-CoV-2 Breakthrough Infection (2023) (0)
Myocardial salvage after reperfusion. Observations from analysis of serial electrocardiographic and biochemical indices. (1992) (0)
SOLUBLE ST2 AND HIGH SENSITIVITY CARDIAC TROPONIN-T LEVELS PREDICT ATRIAL FIBRILLATION ABLATION OUTCOME (2016) (0)
386 Cardiac Testing of Patients Ruled Out for Acute Myocardial Infarction Using a Rapid High Sensitivity Troponin I Algorithm, but Not Discharged (2020) (0)
CAN A SECOND MEASUREMENT OF COPEPTIN IMPROVE ACUTE MYOCARDIAL INFARCTION RULE OUT (2014) (0)
Abstract P091: Performance Of Glycated Albumin As A Marker Of Hyperglycemia During Pregnancy: Results From The National Health And Nutrition Examination 1999-2004 (2022) (0)
Heart-type Fatty Acid Binding Protein as a Marker of Ischaemia in Patients Undergoing Percutaneous Coronary Intervention (2015) (0)
Non-Invasive Detection of Reperfusion after Thrombolysis Using Rapid CK-MB Analysis (2017) (0)
Novel Risk Panel for CAD and All-Cause Mortality in Type 1 Diabetes (2018) (0)
Cardiac troponin I measurement : Confl uence of clinical need and assay performance Emergence of cardiac troponin measurement on the Dimension Vista (2012) (0)
Abstract 16572: High Sensitive Cardiac Troponin T Predicts Long-Term Risk of Incident HF Independent of Cardiovascular Risk Factors and Cardiac Structure/Function in a Multi-Ethnic Population Without CVD: The Multi-Ethnic Study of Atherosclerosis (2016) (0)
Assessing Reperfusion and Prognostic Infarct Sizing with Biochemical Markers (2003) (0)
Personalized diagnosis in suspected myocardial infarction. (2023) (0)
Risk prediction of major adverse cardiac events by high sensitivity troponin is modified by comorbidities (2021) (0)
Performance of glycated albumin as a biomarker of hyperglycemia in pregnancy: Results from the National Health and Nutrition Examination Survey 1999-2004. (2022) (0)
Monocyte chemoattractant protein-1 is not predictive of cardiac events in patients with non-low-risk chest pain (2021) (0)
DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS OF UTILIZING A HIGH SENSITIVE CARDIAC TROPONIN I ASSAY FOR EVALUATION OF “LOW-RISK” CHEST PAIN PATIENTS (2011) (0)
ST2 FOR STRATIFYING PRESERVED EJECTION FRACTION PATIENTS WITH SHORTNESS OF BREATH (2010) (0)
Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in a Population-Based Sample of US Children and Adolescents. (2023) (0)
Concentration of hs-Troponin in small cohort of transgender patients. (2022) (0)
Pediatric Reference Ranges for Cardiac Biomarkers in Health-Paucity Is the Enemy of Good. (2023) (0)
Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH‐Sodium Trial (2023) (0)
Results from healthy donors for novel point-of-care high-sensitivity troponin test (2023) (0)
Practice Guidelines : Clinical Utilization of Cardiac Biomarker Testing in Heart Failure WRITING GROUP MEMBERS (2007) (0)
Reply to Vipin D. Shah (1996) (0)
High-Sensitivity Troponin T and I Among Pregnant Women in the US-the National Health and Nutrition Examination Survey, 1999-2004. (2023) (0)
Abstract 16981: Gender-specific Differences in High-sensitive Cardiac Troponin T and B-type Natriuretic Peptides Across the Spectrum of Aging in CVD-Free Adults: The Multi-Ethnic Study of Atherosclerosis (MESA) (2016) (0)
Incidence and Durability of SARS-CoV-2 Antibodies in Patients with Cancer and Health Care Workers following the First Wave of the Pandemic (2022) (0)
3 Non-specific ECG Findings in Patients with Low High-Sensitivity Troponin Values Are Not Associated With Significant 30-day Adverse Outcomes (2020) (0)
IMPACT OF MALIGNANT LEFT VENTRICULAR FUNCTION ON INCIDENT HEART FAILURE WITH REDUCED VERSUS PRESERVED EJECTION FRACTION: THE MESA STUDY (2017) (0)
HIGH SENSITIVITY TROPONIN VALUES RAPIDLY RULE-OUT MYOCARDIAL INFARCTION AND ALLOW FOR ED DISCHARGE IN A HIGHER RISK PATIENT POPULATION COMPARED TO CONTEMPORARY PRACTICE (2020) (0)
Evaluation of European Society of Cardiology (ESC) 0/1-hour algorithm in the diagnosis of 90-day major adverse cardiovascular events: a multicenter United States cohort study (2020) (0)
Point/Counterpoint: Put Simply - Standardization of Cardiac Troponin I is Complicated | NIST (2011) (0)
for Biomarkers of Heart Failure Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues National Academy of Clinical Biochemistry and IFCC Committee for Standardization of (2013) (0)
Management of cerebrospinal fluid. (1990) (0)
Abstract 5010: Determining the Plasticity of Cardiovascular Risk in the Elderly: A role for serial NT-proBNP measurement (2008) (0)
MID-REGIONAL PROADRENOMEDULLIN PREDICTS LONG-TERM MORTALITY IN PATIENTS WITH CHEST PAIN (2014) (0)
Contents Vol. 137, 2017 (2017) (0)
Kidney Function Specific Reference Limits for N-terminal Pro Brain Natriuretic Peptide and High Sensitivity Troponin T: The Systolic Blood Pressure Intervention Trial (2022) (0)
Abstract 49: The Effects of Vitamin D Supplementation on Subclinical Cardiovascular Disease: Results From the Sturdy Trial (2023) (0)
Multicenter evaluation of a new turbidimetric Cystatin C assay for use on cobas c, Roche/Hitachi and COBAS INTEGRA (R) systems (2008) (0)
The Passing of a Great Humanist. (2018) (0)
MYOCARDIAL MICRO-INJURY IS ASSOCIATED WITH IMPAIRED LV SYSTOLIC AND DIASTOLIC FUNCTION IN OLDER COMMUNITY-BASED INDIVIDUALS WITHOUT CARDIOVASCULAR DISEASE - ASSESSMENT BY SPECKLE TRACKING ECHOCARDIOGRAPHIC MEASUREMENT OF LV AND LA STRAIN: THE CARDIOVASCULAR HEALTH STUDY (CHS) (2019) (0)
111 Delayed Stress-Delta High Sensitivity Troponin Does Not Elevate With Myocardial Ischemia (2015) (0)
HEPARIN-INDUCED THROMBOCYTOPENIA IN MEDICAL ICU: HITTING BACK AT OVER-TESTING (2019) (0)
Abstract 17890: High-Sensitivity Troponin-T Predicts Elevated Fibrosis Markers in Adults Aged ≥ 65 Years with Heart Failure (2010) (0)
THE EFFECTS OF PHYSICAL ACTIVITY ON AMINO-TERMINAL B-TYPE NATRIURETIC PEPTIDE CONCENTRATIONS IN A COHORT OF OLDER ADULTS FREE OF HEART FAILURE (2011) (0)
Cerebrospinal fluid: electrophoresis and methods for determining immunoglobulin G compared. (1989) (0)
Performance characteristics of the creatine kinase-MB mass assay on the Vitros ECi analyzer. (1999) (0)
Abstract 14697: Left Ventricular Mass, Biomarkers of Myocardial Injury and Hemodynamic Stress, and Incident Heart Failure in Older Adults: The Cardiovascular Health Study (2013) (0)
Patients with known coronary artery disease who are ruled out for acute myocardial infarction using a high sensitivity troponin T 0/1-hour algorithm have increased 30-day major adverse cardiac events (2022) (0)
Celebrating AACC's 70th Anniversary: 1948 to 2018-A Thank-you Note to the Founders. (2018) (0)
List of contributors (2020) (0)
FIVE-YEAR CHANGE IN N-TERMINAL FRAGMENT OF THE PROHORMONE BRAIN-TYPE NATRIURETIC PEPTIDE (NT-PROBNP) PREDICTS HEART FAILURE AND DEATH IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: THE HEART AND SOUL STUDY (2013) (0)
Abstract 16606: High-sensitive Cardiac Troponin T Level is Associated With Replacement Fibrosis in Community-dwelling Adults Without Known Cardiovascular Disease: the Multi-Ethnic Study of Atherosclerosis (MESA) (2016) (0)
Traumatic Brain Injury: Combining GFAP and UCH1-L1 Serum Biomarkers Predicts Head CT Outcomes (2018) (0)
Abstract 15753: High-Sensitivity Cardiac Troponin T and Secondary Events in Outpatients with Coronary Heart Disease: Data from the Heart and Soul Study (2012) (0)
Abstract P387: Effects of Reduced Dietary Sodium and the Dash Diet on Glomerular Filtration Rate: Results From the Dash-Sodium Trial (2023) (0)
Corrigendum to “Performance of a no-pretreatment Tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer” [Clinica Chimica Acta 384 (2007) 48–51] (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert H. M. Christenson?

Robert H. M. Christenson is affiliated with the following schools:

Robert H. M. Christenson's Academic­Influence.com Rankings

Why Is Robert H. M. Christenson Influential?

Robert H. M. Christenson's Published Works

Published Works

What Schools Are Affiliated With Robert H. M. Christenson?

Robert H. M. Christenson's AcademicInfluence.com Rankings